GAM
CERE

Gotham Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Gotham Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,310
Closed -$340K – 1547
2024
Q2 		$340K Hold
8,310
– – ﹤0.01% 1195
2024
Q1 		$351K Sell
8,310
-1,084
-12% -$45.5K 0.01% 1151
2023
Q4 		$398K Buy
+9,394
New +$270K 0.01% 1055

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Gotham Asset Management's CERE Position: Q3 2024 in Review

Gotham Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 8,310 shares — an estimated $340K sold.

Gotham Asset Management first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $398K in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Gotham Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Gotham Asset Management sold 8,310 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $340K.
  • Gotham Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Gotham Asset Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $398K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Gotham Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.